DA ROS, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.836
AS - Asia 882
EU - Europa 836
AF - Africa 161
SA - Sud America 119
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 13
Totale 3.863
Nazione #
US - Stati Uniti d'America 1.735
IT - Italia 377
SG - Singapore 375
CN - Cina 195
HK - Hong Kong 82
NL - Olanda 73
BR - Brasile 62
DE - Germania 58
VN - Vietnam 53
FI - Finlandia 52
SE - Svezia 43
PL - Polonia 37
GB - Regno Unito 22
FR - Francia 20
RU - Federazione Russa 20
IN - India 19
CA - Canada 15
TR - Turchia 12
MX - Messico 11
ZA - Sudafrica 11
AR - Argentina 10
UZ - Uzbekistan 10
AU - Australia 9
BJ - Benin 9
IE - Irlanda 9
JP - Giappone 9
PY - Paraguay 9
BO - Bolivia 8
IL - Israele 8
MK - Macedonia 8
PE - Perù 8
AT - Austria 7
BB - Barbados 7
CH - Svizzera 7
DO - Repubblica Dominicana 7
IR - Iran 7
IS - Islanda 7
JM - Giamaica 7
KR - Corea 7
RW - Ruanda 7
BE - Belgio 6
CM - Camerun 6
CW - ???statistics.table.value.countryCode.CW??? 6
DK - Danimarca 6
EG - Egitto 6
ES - Italia 6
HU - Ungheria 6
ID - Indonesia 6
IQ - Iraq 6
NG - Nigeria 6
PA - Panama 6
PR - Porto Rico 6
RS - Serbia 6
SA - Arabia Saudita 6
SI - Slovenia 6
SO - Somalia 6
UA - Ucraina 6
XK - ???statistics.table.value.countryCode.XK??? 6
AL - Albania 5
BD - Bangladesh 5
CG - Congo 5
CL - Cile 5
CR - Costa Rica 5
DZ - Algeria 5
EC - Ecuador 5
EE - Estonia 5
GE - Georgia 5
GH - Ghana 5
HR - Croazia 5
HT - Haiti 5
JO - Giordania 5
KE - Kenya 5
KZ - Kazakistan 5
LA - Repubblica Popolare Democratica del Laos 5
LB - Libano 5
LC - Santa Lucia 5
LV - Lettonia 5
MA - Marocco 5
MD - Moldavia 5
MR - Mauritania 5
NE - Niger 5
PT - Portogallo 5
TH - Thailandia 5
TJ - Tagikistan 5
TZ - Tanzania 5
YT - Mayotte 5
AD - Andorra 4
AE - Emirati Arabi Uniti 4
BW - Botswana 4
CI - Costa d'Avorio 4
CO - Colombia 4
CV - Capo Verde 4
GA - Gabon 4
GN - Guinea 4
MN - Mongolia 4
MQ - Martinica 4
MY - Malesia 4
MZ - Mozambico 4
NP - Nepal 4
PS - Palestinian Territory 4
Totale 3.736
Città #
Ashburn 248
Singapore 210
Fairfield 178
Chandler 166
Woodbridge 154
Houston 96
Ann Arbor 90
Santa Clara 90
Hong Kong 73
Seattle 71
Wilmington 69
Cambridge 67
Beijing 62
Boardman 30
Milan 30
Bytom 28
Helsinki 27
Los Angeles 27
Des Moines 24
Medford 22
Princeton 22
Rome 18
Dong Ket 16
Guangzhou 15
Roxbury 15
San Diego 15
Padova 14
Hanoi 12
Munich 12
New York 11
Turin 10
Turku 10
Florence 9
Ho Chi Minh City 9
Nanjing 9
Naples 9
Tashkent 9
Buffalo 8
Cotonou 8
Kigali 7
Lima 7
Redondo Beach 7
Stockholm 7
Bridgetown 6
Cagliari 6
Dublin 6
Johannesburg 6
Skopje 6
São Paulo 6
Warsaw 6
Accra 5
Amman 5
Atlanta 5
Bari 5
Bologna 5
Boston 5
Brooklyn 5
Castries 5
Chicago 5
Council Bluffs 5
Dushanbe 5
Falls Church 5
Hefei 5
Lagos 5
Ljubljana 5
Marigliano 5
Mumbai 5
Niamey 5
North Bergen 5
Nouakchott 5
Padua 5
Panama City 5
Pristina 5
Riga 5
San Juan 5
Shenyang 5
Tokyo 5
Verona 5
Willemstad 5
Almaty 4
Andorra la Vella 4
Belgrade 4
Cochabamba 4
Conakry 4
Dar es Salaam 4
Escanaba 4
Fisciano 4
Giugliano in Campania 4
Harare 4
Hargeisa 4
Kingston 4
Libreville 4
London 4
Lucca 4
Maputo 4
Montreal 4
Nairobi 4
Orem 4
Osaka 4
Praia 4
Totale 2.292
Nome #
Oncogene c-KIT: promoter region and downstream effectors as novel therapeutic targets 571
Screening of candidate G-quadruplex ligands for the human c-KIT promotorial region and their effects in multiple in-vitro models 223
DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma 202
G-Quadruplex Modulation of SP1 Functional Binding Sites at the KIT Proximal Promoter 185
Sequencing and G-quadruplex folding of the canine proto-oncogene KIT promoter region: might dog be used as a model for human disease? 178
In Silico Identification of Piperidinyl-amine Derivatives as Novel Dual Binders of Oncogene c-myc/c-Kit G-quadruplexes 178
Indenocinnoline derivatives as G-quadruplex binders, topoisomerase IIα inhibitors and antiproliferative agents 176
G-rich sequences within proto-oncogene KIT promoter region as targets for anticancer therapy. 170
DNA targeting by cationic porphyrin-ruthenium(II) conjugates 162
Impairment of c-kit expression in human cancer cell lines by a novel pharmacophoric unit selected for the recognition of the proto-oncogene KIT promotorial region. 162
Hypermethylation-Mediated Silencing of CIDEA, MAL and PCDH17 Tumour Suppressor Genes in Canine DLBCL: From Multi-Omics Analyses to Mechanistic Studies 162
Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach. 161
DNA elements for constitutive androstane receptor- and pregnane X receptor-mediated regulation of bovine CYP3A28 gene 158
Role of the Benzodioxole Group in the Interactions between the Natural Alkaloids Chelerythrine and Coptisine and the Human Telomeric G-Quadruplex DNA. A Multiapproach Investigation 149
Targeting canine c-KIT promoter by a candidate DNA G-quadruplex ligand 148
Targeting canine kit promoter by candidate DNA G-quadruplex ligands 147
Factors underlying the increase in carotid intima-media thickness in borderline hypertensives 142
Targeting Canine KIT Promoter by a Candidate DNA G-quadruplex Ligand 138
A G-quadruplex binding compound down-regulates KIT, BCL2 and PDGFRβ expression in human gastric carcinoma cell line 137
Evaluation of epigenetic mechanisms regulating HOXD10, FGFR2 and ITIH5 gene expression in canine B-cell lymphoma: an in vitro approach. 106
Characterization of the promoter region of the proto-oncogene c-kit in canine mast cell tumour 95
Characterization of the promoter region of the proto-oncogene c-Kit in canine mast cell tumour 93
CONFIRMATORY STUDIES ON THE TRANSCRIPTIONAL REGULATION OF BOVINE CYP3A28 GENE 62
Totale 3.905
Categoria #
all - tutte 11.148
article - articoli 6.809
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.957


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021157 0 0 0 0 0 3 31 13 25 38 26 21
2021/2022286 2 47 25 18 12 30 17 24 6 6 28 71
2022/2023306 52 48 1 47 35 33 4 15 40 6 21 4
2023/2024203 3 19 28 10 24 14 16 28 6 21 14 20
2024/2025924 15 50 49 39 135 57 67 77 91 35 125 184
2025/20261.333 175 157 305 387 257 52 0 0 0 0 0 0
Totale 3.905